Remove Biohazard Remove Engineer Remove Research
article thumbnail

IBC vs. IRB: What’s the Difference?

Advarra

Gene therapy research is exciting and full of promise, but because of the risks involved, it’s also highly regulated, requiring an institutional biosafety committee (IBC) to provide additional oversight and risk assessment. IRBs are tasked with protecting research subject’s rights and welfare. What Does an IBC Review?

article thumbnail

Safe Sharps Handling When Dispensing Investigational Products

Advarra

Injuries from sharps in a research or clinical setting are a serious problem for employees, as the CDC estimates almost 400,000 needlesticks and other sharps-related injuries occur to healthcare personnel each year. A loaded syringe can be safely capped using either: A safety engineered syringe. Safety-engineered Syringes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clean Bench vs Biosafety Cabinet: What’s the Difference?

Advarra

This article explores how these tools work and why biosafety cabinets are preferred in research involving cell and gene therapies. Why Does the IBC Prefer Researchers use a Biosafety Cabinet vs a Clean Bench? In the case of IBC review, we’re preventing exposure to biologics such as engineered genetic materials and/or infectious agents.

article thumbnail

Thinking About the Box: Considerations for Transport of Investigational Products

Advarra

Controlled Environment and IP Containment The potential for a release, and the risk associated with a genetically engineered IP, are part of the IBC’s assessment purview under National Institutes of Health (NIH) Guidelines. And don’t forget to affix a biohazard sticker to the exterior for quick and clear identification.